[Second line AUO study AB35/09 of metastasized urothelial cell carcinoma].
Rexer
H
H
MeckEvidence, Seestrasse 11, 17252, Schwarz, Deutschland. AUO@MeckEvidence.de
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D002277:Carcinoma / Q000188:drug therapy* / Q000556:secondary*; D000068338:Everolimus; D006801:Humans; D017239:Paclitaxel / Q000008:administration & dosage*; D020123:Sirolimus / Q000008:administration & dosage / Q000031:analogs & derivatives*; D016896:Treatment Outcome; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000556:secondary*
D000068338:Everolimus; D017239:Paclitaxel; D020123:Sirolimus